SCHEMBL10107798

SCHEMBL10107798

CCCOc1ccc(C(=O)CCN2CCOCC2)cc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 9/20 0.88
ALDH1A1 P00352 6/20 0.88
MAPT P10636 5/20 0.88
LMNA P02545 3/20 0.88
KMT2A Q03164 2/20 0.88
THRA P10827 5/20 0.84
TSHR P16473 1/20 0.75
SMN1; SMN2 Q16637 3/20 0.73
GAA P10253 1/20 0.73
HRH2 P25021 2/20 0.69
HRH1 P35367 2/20 0.69
HRH3 Q9Y5N1 2/20 0.69
CYP1A2 P05177 1/20 0.69
CHRM2 P08172 1/20 0.69
CHRM4 P08173 1/20 0.69
CHRM5 P08912 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C9 P11712 1/20 0.69
ADRA2C P18825 1/20 0.69
DRD4 P21917 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11222638 0.95 THRB (0.97) THRBALDH1A1MAPTLMNAKMT2A
SCHEMBL21641953 0.91 THRB (1.00) THRBALDH1A1MAPTLMNAKMT2A
SCHEMBL21663339 0.91 THRB (1.00) THRBALDH1A1MAPTLMNAKMT2A
SCHEMBL863522 0.90 SMN1; SMN2 (0.81) THRBALDH1A1MAPTLMNAKMT2A
SCHEMBL29508033 0.88 THRB (0.84) THRBALDH1A1MAPTLMNAKMT2A
SCHEMBL29378842 0.87 ALDH1A1 (0.97) THRBALDH1A1MAPTLMNAKMT2A
Propipocaine SCHEMBL25430 0.87 ALDH1A1 (0.97) THRBALDH1A1MAPTLMNAKMT2A
Propipocaine SCHEMBL4457156 0.86 ALDH1A1 (1.00) THRBALDH1A1MAPTLMNAKMT2A
Propipocaine SCHEMBL1650998 0.85 ALDH1A1 (0.93) THRBALDH1A1MAPTLMNAKMT2A
SCHEMBL12670301 0.84 SMN1; SMN2 (1.00) THRBALDH1A1MAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010248-A1 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-01-12 US disclosed
US-20120010248-A1 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010248-A1 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof ALDH2, ALDH5A1, AK2 THRB 2532/4885ALDH1A1 13/4885MAPT 2033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.